• How FUS–SMN Interactions Build Neuronal RNA Granules

  2026-09-28

  Wang and Li show that asymmetric dimethylation of FUS creates binding opportunities for oligomeric SMN, promoting FUS phase separation and neuronal granule formation. Their results connect methylation and protein multivalency to axonal mRNA distribution, while identifying limitations relevant to interpreting these condensates in cells.

• Ruxolitinib phosphate in JAK/STAT Research

  2026-09-27

  Use Ruxolitinib phosphate (INCB018424) to separate JAK1/2-dependent signaling from downstream cell responses, with a workflow that spans rapid phospho-readouts and later cell-death phenotypes. A 2024 anaplastic thyroid cancer study adds a testable connection between STAT3 activity, DRP1 expression, mitochondrial fission, apoptosis, and GSDME-mediated pyroptosis.

• DiR (DiIC 18 (7)) for Cell and Tissue Tracking

  2026-09-26

  DiR enables long-lived, deep-red membrane labeling for cell tracking, neuronal tracing, and tissue imaging where visible dyes can be limited by autofluorescence. This guide turns its membrane-partitioning behavior into practical workflows and controls—and explains how to use it as a distribution readout without mistaking fluorescence for therapeutic mechanism.

• Deracoxib Workflows for COX-2 Research

  2026-09-25

  Deracoxib enables controlled studies of COX-2 inhibition across inflammation and canine tumor models, but its effects depend strongly on cell type and concentration. This workflow pairs dose-response testing with orthogonal viability, apoptosis, and cell-cycle readouts so researchers can distinguish pathway effects from high-dose cytotoxicity.

• DCPS Links m7G Regulation to Diabetic Foot Ulcer Repair

  2026-09-25

  A 2025 study identifies the decapping scavenger enzyme DCPS as a candidate diabetic foot ulcer biomarker and links reduced DCPS expression to impaired epithelial cell-cycle progression, proliferation, and migration. Its combination of transcriptomic analysis, tissue validation, and keratinocyte knockdown experiments supports further investigation, while leaving the precise m7G-dependent mechanism and clinical utility to be established.

• Cy5 Maleimide for Protein Labeling & Condensate Assays

  2026-09-24

  Cy5 maleimide enables cysteine-directed protein labeling for tracking, imaging, and fluorescence assays—with red-channel detection that can be adapted to condensate-partitioning studies. A practical workflow pairs careful thiol chemistry with controls that reveal when the dye itself changes protein behavior.

• Cyanine 5-dCTP: Design Labels for Reliable DNA Readout

  2026-09-24

  Cyanine 5-dCTP enables red-fluorescent DNA labeling, but reliable results depend on balancing polymerase acceptance with signal density. This guide connects Cy5-dCTP chemistry to practical assay decisions and explains how DNA-framework synthesis research informs—but does not validate—labeling workflows.

• One-step TUNEL Cy5 Apoptosis Detection Kit

  2026-09-23

  A practical guide to choosing, running, and interpreting a TUNEL assay across cultured cells and tissue samples. It explains the documented wavelength and storage specifications of the One-step TUNEL Cy5 Apoptosis Detection Kit (SKU K1135), plus key controls and interpretation limits.

• Cy3 Maleimide Maps Repair at Stalled Forks

  2026-09-23

  Replication stress exposes a central challenge in translational biology: distinguishing where repair factors accumulate from how they interact. This thought-leadership guide connects linker histone H1 phosphorylation, ssDNA assembly, and HPF1 recruitment with a practical strategy for using Cy3 maleimide (non-sulfonated) in mechanistic fluorescence assays.

• APOC1 and Cyclopamine in Papillary Thyroid Carcinoma

  2026-09-22

  A 2026 Translational Oncology study identifies APOC1 as a pro-tumorigenic and immune-evasion-associated factor in papillary thyroid carcinoma (PTC), then uses Connectivity Map analysis to nominate Cyclopamine as a candidate treatment. The work combines patient-data analysis, APOC1 perturbation, cell-based assays, and a mouse model to show that APOC1 depletion sensitizes PTC cells to Cyclopamine-mediated growth inhibition and apoptosis.

• Amikacin Sulfate: Assays, Delivery & Troubleshooting

  2026-09-22

  Amikacin Sulfate supports a practical progression from concentration-response and intracellular killing assays to granuloma-targeted delivery studies. This guide explains how to separate antibacterial potency from host-cell effects, use KR-12 research as a delivery-design reference, and troubleshoot common CFU and viability failures.

• GSH-Responsive MOF Nanoparticles for Melanoma

  2026-09-21

  Hao and colleagues developed ICG-loaded, AUNP12-functionalized metal–organic framework nanoparticles that combine photothermal therapy with PD-1/PD-L1 checkpoint inhibition. The platform uses glutathione-responsive release and 808 nm near-infrared irradiation to link tumor-cell ablation with dendritic-cell maturation and immune activation, while also highlighting the experimental controls needed when adapting related cyanine dyes.

• Cytochalasin B: From Actin Mechanism to Translation

  2026-09-21

  Cytochalasin B, also known as NSC 107658, is more than an actin-disrupting reagent: it is a reversible pharmacological stress test for distinguishing cytoskeletal dependence from generalized loss of cell fitness. This thought-leadership guide connects its barbed-end mechanism with assay design, toxicology controls, translational decision-making, and the strategic needs of modern drug discovery.

• ARCA Cy5 EGFP mRNA: A Benchmarking Framework

  2026-09-20

  ARCA Cy5 EGFP mRNA (5-moUTP) enables a decision-oriented framework for separating cellular uptake, intracellular localization, and productive translation. This article connects fluorescent reporter design with mRNA delivery system research and translational assay strategy.

• ML133 HCl: Kir2.1 Inhibition Workflow

  2026-09-19

  Build a pH-aware, causality-focused workflow around ML133 HCl, a selective potassium channel inhibitor for Kir2.1 studies. The approach connects acute channel pharmacology with pulmonary artery smooth muscle cell proliferation, migration, and vascular-remodeling assays while emphasizing controls, solubility, and interpretation.

7994 records 1/533 page Next 12345 下5页 Last page